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PANCREATIC ISLET CELL AND
OTHER TUMOURS INDUCED IN
RATS BY HELIOTRINE- A MONO-
ESTER PYRROLIZIDINE ALKALOID;
THE EFFECTS OF ADDITIONAL
TREATMENT WITH NICOTINAMIDE.
R. SCHOENTAL, The Royal Veterinary
College, London.
The carcinogenic action of diester pyr-
rolizidine alkaloids (Schoental, Cancer Res.,
1968, 28, 2237) has been confirmed in several
laboratories (Harris and Chen, Cancer Res.,
1970, 30, 2881; Svoboda and Reddy, ibid.,
1972, 32, 908; Newberne and Rogers, Plant
Foods for Man, 1973, 1, 23).
The mono-ester alkaloid, heliotrine, has
been claimed not to be carcinogenic (Bull,
Culvenor and Dick, The Pyrrolizidine Alka-
loids, 1968, North Holland Publishing Co.).
In experiments to be described, heliotrine
induced in white rats various chronic lesions
and tumours, including adenomata of the
pancreatic islet cells. Pancreatic islet cell
tumours have already been described among
rats treated with pyrrolizidine alkaloids,
including the mono-esters from Amsinckia
intermedia (Schoental, Fowler and Coady,
Cancer Res., 1970, 30, 2127).
TREATMENT OF A METASTASIZING
MURINE TUMOUR WITH CORYNE-
BACTERIUM PARVUM. T. E. SADLER
and J. E. CASTRO, Urology and Transplant
Unit, Royal Postgraduate Medical School,
London.
Effects of Corynebacteriun parvum (C.
parvum) on the metastasizing Lewis lung
carcinoma were studied in C57/B1 mice.
Intravenous or intraperitoneal C. parvum
given at the same time as subcutaneous
inoculation of tumour significantly reduced
the primary tumour mass, and the number
of pulmonary metastases observed at 21
days. Subcutaneous C. parvum had no
effect on either primary tumour or meta-
stases. Macroscopic pulmonary metastases
were not observed 10 days after tumour
inoculation. When the primary tumour
was excised at that time pulmonary meta-
stases were found at 21 days.
Combined effects of surgical excision and
C. parvum on pulmonary metastases were
studied. There was minimal protection when
C. parvUm, and surgery wAere on the same
day but protection occurred when C. parvrum
was given before tumour excision.
In defined conditions surgery and C.
parvum prevent pulmonary metastases from
the Lewis tumour. (This work is supported
by the Cancer Research Campaign.)
MECHANISM OF ACTION OF TU-
MOUR INHIBITORY NITROSO-
UREAS. T. A. CONNORS and J. R. HARE,
Chester Beatty Research Institute, London.
1,3 - Bis(2 - chloroethyl) - 1 - nitrosourea
(BCNU) and related nitrosoureas are highly
selective anti-tumour agents. Because of
their chemical structure, it has been sug-
gested that they act similarly to the bi-
functional alkylating agents. They have
been compared with two alkylating agents
and shown to be quite distinct in a number
of properties: (1) They have a much wider
spectrum of action and can cure animals
with tumours insensitive to alkylating agents;
(2) tumours resistant to BCNU are cross-
resistant to other nitrosoureas but are
collaterally sensitive to alkylating agents;
(3) nitrosoureas rapidly inhibit the incorpora-
tion of precursors into both nucleic acids and
proteins, unlike the alkylating agents which
have a specific effect on thymidine incorpora-
tion into DNA; (4) labelled nitrosoureas
react predominantly with nuclear protein and
only to a small extent with nucleic acids;
(5) BCNU interferes specifically with the
incorporation of thymidine triphosphate into
DNA, and its cytotoxicity can be prevented
by low doses of thymidine.
Although the toxicity of the nitrosoureas
may be due partly to their alkylating
properties, they are quite distinct from the
bifunctional alkylating agents and probably
act by a different mechanism.
DISTRIBUTION STUDIES WITH AN
AMINOPHOSPHONIC ACID ANA-
LOGUE OF DOPA IN MICE BEARING
THE HARDING-PASSEY MELANOMA.
M. J. STRINGER, J. A. STOCK and L. M.
COBB, Chester Beatty Research Institute,
London.
A compound which is incorporated select-
ively into melanin during biosynthesis in
vivo, and which carries an isotope ofadequate
radiotoxicity and short half-life, has a
potential application in the treatment of
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be expected to be of particular value in
tumours producing large amounts ofmelanin.
Underthese circumstances,malignantmelano-
cytes would be likely to sustain more dainage
than normal melanocytes, particularly if
the patient were kept away from direct
sunlight.
32pwas considered to be themostsuitable
available radionuclide and DL-1-amino-2-
(3,4-dihydroxyphenyl)-ethyl-phosphonic acid
(ADEP), an analogue of DOPA, was made
and investigated as a possible carrier. Pre-
liminary distribution studies were carried
out with tritiated ADEP in mice bearing
the Harding-Passey melanoma. Thehighest
initial tritium concentration was in the
kidneys, adrenal glands and eyes. Radio-
activity fell to low levels in all tissues in
8 days or less but the tumour retained the
isotope longer than did other tissues.
Structural analogues of ADEP which
may be taken up more selectively by melan-
oma tissues are being considered.
TRANSPLANTABLE ADENOCARCI-
NOMATA OF THE COLON IN MICE
AS POSSIBLE MODELS FOR CHEMO-
THERAPY. C. R. BALL and J. A. DOUBLE,
Department of Cancer Research, University
of Leeds.
Dimethylhydrazine treatment (17 weekly
subcutaneous injections) of NMRI mice
results in a 100% incidence of tumours of
the colon by 22 weeks (Haase et al., Br. J.
Cancer, 1973, 28, 530). Primary tumours
derived in such mice have been transplanted
into syngeneic mice and have resulted in
5 transplantable tumour lines from 51
attempts.
The 5 transplant lines (MAC7, MACIO,
MAC13, MAC14, MAC15) are all well dif-
ferentiated adenocarcinomata, some mucin
secreting; each has its own characteristic
growth rate (3-16 weeks to reach 5 x 5 mm
from an implanted fragment) and thymidine
labelling index (12-24%); all have 100%
take rates; there is no evidence of de-
differentiation during successive transplant
generations (up to 8 in one case).
Methods have been developed for using
the tumours MAC13 and MAC15 for chemo-
therapy screening. Initial studies of sensi-
tivity to single dose therapy with 5-fluoro-
uracil, cyclophosphamide, BCNU, CCNU,
MeCCNU and methotrexate indicate (i) a
general insensitivity to chemotherapy; (ii)
that each tumour line has its own spectrum
of sensitivity each responding to about half
the drugs tested; and (iii) that the tumours
are amenable to further development as
possible screening models for drugs active
against colorectal cancer.
EFFECTS OF AGE AND CARCINOGEN
TREATMENT ON CELL GROWTH
IN ORGAN CULTURES OF ADULT
MOUSE COLON. E. A. DEFRIES and
L. M. FRANKS, Imperial Cancer Research
Fund, London.
As most differentiated epithelial cells
cannot be maintained in monolayer culture,
most of the work on chemical carcinogenesis
in vitro is done using cultures of undiffer-
entiated mesenchymal cells.
Although embryonic intestine can be
maintained in organ culture for several
weeks, previous tissue culture experiments
using adult intestinal tissue had been
restricted to 24-48 h. We have established
an organ culture system by which adult
mouse colon can be maintained, in a modified
form, for at least 28 days.
After an initial degenerative phase the
explants are covered by a layer of well
differentiated surface epithelium with a
variable number of crypts extending into
the lamina propria. Cell division is confined
to the crypts and cells move out of the
crypts into the surface compartment. These
cultures have been used for studies on the
effect of donor age and carcinogen pretreat-
ment on subsequent mitotic index in vitro.
Preliminary experiments appear to show that
carcinogen treatment alters the growth
capacity of the intestinal epithelial cells
though they remain responsive to the
growth controlling mechanisms in the intact
animal.
EFFECTS OF PROTEOLYTIC EN-
ZYMES AND A SYSTEMIC CARCINO-
GEN ON SURFACE STRUCTURE AND
GROWTH OF ADULT BLADDER
EPITHELIUM IN ORGAN CULTURE.
G. M. HODGES and G. SPAcEY, Imperial
Cancer Research Fund, London and M. D.
Muma, Imperial College, London.
The scanning electron microscope (SEM)
is a useful tool for studying surface changes
in cells in vivo and in vitro and it can also
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